Aiming to let medical practitioners easily and effectively administer intra-dermal, subcutaneous and intramuscular injections to patients without the use of needles, the country’s first ever Needle-Free Injection Technology (NFIT) was launched on Saturday.
iHealthNet, a US-registered company introduced the technology at a city hotel.
Designed by the USA-based NFIT developer and manufacturer Bioject Medical Technologies, the products offer patients with enhanced safety, compliance and quality of life, while reducing risks associated with typical syringe injectors, and elimination sharps waste disposal, said organisers at the programme.
Under a joint agreement, the Bioject Medical Technologies Inc will manufacture the products and iHealthNet, LLC will promote and distribute it.
The programme introduced two separate products – Biojector 2000, a gas powered device, and the Bioject ZetaJet.
Capable of delivering variable doses of medication up to 1.0mL, the “Biojector 2000,” a portable device enables healthcare professionals to reliably deliver measured adjustable doses of medication through the skin, either intramuscularly or subcutaneously, without a needle.
On the other hand, “ZetaJet,” a needle-free delivery systems, with an auto-disabling disposable syringe, can be used to eliminate accidental needle-stick injuries and reduces sharp waste. The product allows low operating cost and gives enhanced longevity and reliability, which is critical in developed and developing areas.
Chief Executive Officer (CEO) of iHealthNet, Tawfiq Hassan, said the company is excited to introduce the much-awaited needle-free products, which are proven through their current use in the USA and by the World Health Organisation (WHO) in various countries.
“The devices bring relief to users who depend on injections to live a normal life. iHealthNet is proud to announce its partnership with Bioject, and is eagerly looking forward to working with governments and the private sector to distribute these devices in Asia, Africa and Middle East,” he said.
He also demonstrated the process of using the devices.
Bioject’s president and CEO, Mark Logomasini, said: “We are very pleased to have this agreement and are looking forward to expanding the use of our needle-free devices into these territories, and offering the proven benefits of Bioject’s injection delivery systems to a larger global population.”
Tina Hasan, vice president, operations at iHealthNet said millions of people depend on the needle and some of them have needle phobia.
“To overcome the ways, the revolutionary needle-free injection is here to ensure proper hygiene and quality control,” she said.
The inauguration ceremony was attended by entrepreneurs, medical professionals, healthcare workers, and representatives of corporate houses.
